FDA Allergenic Products Advisory Committee
Executive Summary
Will meet July 20 to consider presentations on the Center for Biologics Evaluation and Research Division of Allergenic Products and Parasitology's labs of Immunoregulation, Immunobiochemistry, Parasitology and Biochemistry, and Biophysics. The committee also will hear presentations on conversions of radioallergosorbent test (RAST) inhibition assay to the enzyme-linked immunosorbent assay (ELISA); the points to consider document for production and testing of allergenic products; marker proteins, monoclonal antibodies and automation; and conversion of standardized grass pollen extracts to bioequivalent allergy units. The meeting will begin at 8:30 a.m. at the Holiday Inn, Bethesda, Md. Closed committee deliberations will begin at 12:30 p.m.